NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users

BACKGROUND: 3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze the composition of the supposed 3-MMC samples purchased a...

Descripción completa

Detalles Bibliográficos
Autores principales: Willeman, Théo, Grundig, Nathan, Pochon, Christine, Michels, David, Charpentier, Nicolas, Eysseric-Guérin, Hélène, Fouilhé Sam-Lai, Nathalie, Stanke-Labesque, Françoise, Revol, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375651/
https://www.ncbi.nlm.nih.gov/pubmed/37507699
http://dx.doi.org/10.1186/s12954-023-00836-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375651/
https://www.ncbi.nlm.nih.gov/pubmed/37507699
http://dx.doi.org/10.1186/s12954-023-00836-4

Ejemplares similares